These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6284464)

  • 21. Studies on nasopharyngeal carcinoma in Thailand.
    Premabutr P; Thomson S; Srivatanakul P
    J Med Assoc Thai; 1974 Apr; 57(4):191-6. PubMed ID: 4377011
    [No Abstract]   [Full Text] [Related]  

  • 22. Nasopharyngeal carcinoma. VII. B and T lymphocytes in the circulating blood and in tumour tissue.
    Yata J; Desgranges C; De-Thé G; Mourali N; Ellouz R; Tachibana T; Brugere J
    Biomedicine; 1974 Jun; 21(6):244-50. PubMed ID: 4374264
    [No Abstract]   [Full Text] [Related]  

  • 23. [Distribution of EBV-VCA and EA antibody in the general population in a high incidence area of nasopharyngeal carcinoma].
    Liu YX
    Zhonghua Zhong Liu Za Zhi; 1983 Sep; 5(5):337-9. PubMed ID: 6317314
    [No Abstract]   [Full Text] [Related]  

  • 24. [Investigation of 2 families with clustering of nasopharyngeal carcinoma and detection of serum VCA-IgA antibody among their members].
    Tang ZH
    Zhonghua Yi Xue Za Zhi; 1983 Sep; 63(9):553-5. PubMed ID: 6317146
    [No Abstract]   [Full Text] [Related]  

  • 25. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT; Yeh CY
    Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Symptomatologic value of the assay of EBV antibodies in carcinoma of the nasopharynx].
    de Thé G
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1983 Oct; 32(8):493-9. PubMed ID: 6319536
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum anti-EBV IgA is inversely related to tumor infiltration by surface IgA positive lymphocytes in nasopharyngeal carcinoma.
    Gunvén P; Klein G; Henle W; Henle G; Forsby N
    Biomed Pharmacother; 1983; 37(1):41-4. PubMed ID: 6311307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnostic evaluation of anti-EBV(VCA and EA) antibody titration in patients with nasopharyngeal carcinoma (author's transl)].
    Takimoto T
    Nihon Jibiinkoka Gakkai Kaiho; 1979 Mar; 82(3):255-62. PubMed ID: 228017
    [No Abstract]   [Full Text] [Related]  

  • 29. Epstein-Barr virus is not associated with head and neck neoplasms other than nasopharyngeal carcinoma.
    Kottaridis SD; Goula I; Kiparissiadis P
    Neoplasma; 1982; 29(3):327-31. PubMed ID: 6290911
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies of the Epstein-Barr herpesvirus relationship with Hodgkin's disease and the use of virus immunological markers in differential diagnostics of nasopharyngeal carcinoma.
    Mazurenko NP; Gurtsevich VE; Stepina VN; Plakhov IV
    Arch Geschwulstforsch; 1983; 53(3):253-9. PubMed ID: 6311138
    [No Abstract]   [Full Text] [Related]  

  • 31. Independent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: a 20-year follow-up study on 9,622 males without family history in Taiwan.
    Hsu WL; Chen JY; Chien YC; Liu MY; You SL; Hsu MM; Yang CS; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1218-26. PubMed ID: 19336547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A study of the practical value of the immunoenzyme method in seroepidemiological field surveys].
    Wu JM
    Zhonghua Liu Xing Bing Xue Za Zhi; 1988 Apr; 9(2):107-10. PubMed ID: 2842055
    [No Abstract]   [Full Text] [Related]  

  • 33. Antibodies to herpes group viruses in patients with nasopharyngeal and other head and neck cancers.
    Henderson BE; Louie E; Bogdanoff E; Henie W; Alena B; Henie G
    Cancer Res; 1974 May; 34(5):1207-10. PubMed ID: 4366990
    [No Abstract]   [Full Text] [Related]  

  • 34. [Virologic-serologic diagnosis of nasopharyngeal cancer].
    Bornkamm GW
    Strahlentherapie Sonderb; 1984; 78():15-21. PubMed ID: 6328701
    [No Abstract]   [Full Text] [Related]  

  • 35. Anticomplement immunoenzymatic method of detecting Epstein-Barr nuclear antigen in nasopharyngeal carcinoma cells and normal epithelial cells.
    Zeng Y; Shen SJ; Pi GH; Ma JL; Zhang Q; Zhao ML; Dong HJ
    Chin Med J (Engl); 1981 Oct; 94(10):663-8. PubMed ID: 6274591
    [No Abstract]   [Full Text] [Related]  

  • 36. [A specific histological marker of undifferentiated carcinoma of the nasopharynx. The ACIF (Anti-Complement Immunofluorescence) test].
    Micheau C; De The G; Schwaab G; Tursz T; Sancho-Garnier H; Montagu B
    Ann Pathol; 1984; 4(2):143-6. PubMed ID: 6329239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Value of anti-Epstein-Barr antibody detection in the diagnosis and management of undifferentiated carcinoma of the nasopharynx].
    Mazeron MC
    Bull Cancer Radiother; 1996; 83(1):3-7. PubMed ID: 8679277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of tumor-virus associated antibodies by mixed hemadsorption.
    Gatti RA; Jonsson J
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:298. PubMed ID: 4368573
    [No Abstract]   [Full Text] [Related]  

  • 39. [Strict correlation between anti-RANA antibodies and anti-EBNA antibodies apart from rheumatoid arthritis. Assessment of the diagnostic value of anti-RANA antibody].
    Cohen JH; Lenoir GM; Colmet-Daage JF; Blanchard F; Etienne JC; Dropsy G; Gougeon J
    Rev Rhum Mal Osteoartic; 1983 Jan; 50(1):3-7. PubMed ID: 6302824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Application of immunoenzymic method and immunoautoradiographic method for the mass survey of nasopharyngeal carcinoma (author's transl)].
    Zeng Y; Liu Y; Liu CR; Chen SW; Wei JE; Zhu JS; Zai HJ
    Zhonghua Zhong Liu Za Zhi; 1979; 1(1):2-7. PubMed ID: 233230
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.